Your browser doesn't support javascript.
loading
Assessment of Safety and Prophylactic Efficacy of the EpiVacCorona Peptide Vaccine for COVID-19 Prevention (Phase III).
Ryzhikov, Alexander B; Ryzhikov, Evgeny A; Bogryantseva, Marina P; Usova, Svetlana V; Nechaeva, Elena A; Danilenko, Elena D; Pyankov, Stepan A; Gudymo, Andrey S; Moiseeva, Anastasiya A; Onkhonova, Galina S; Pyankov, Oleg V; Sleptsova, Ekaterina S; Lomakin, Nikita V; Vasilyeva, Veronika S; Tulikov, Mikhail V; Gusarov, Vitaly G; Pulin, Andrey A; Balalaeva, Maria A; Erofeeva, Svetlana B; Terpigorev, Stanislav A; Rychkova, Olga A; Petrov, Ivan M; Delian, Viktoriia Y; Rafalskiy, Vladimir V; Tyranovets, Sergey V; Gavrilova, Elena V; Maksyutov, Rinat A.
Afiliación
  • Ryzhikov AB; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Ryzhikov EA; Limited Liability Company "EpiVac", 630559 Koltsovo, Russia.
  • Bogryantseva MP; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Usova SV; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Nechaeva EA; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Danilenko ED; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Pyankov SA; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Gudymo AS; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Moiseeva AA; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Onkhonova GS; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Pyankov OV; State Research Center of Virology and Biotechnology "VECTOR", Rospotrebnadzor, 630559 Koltsovo, Russia.
  • Sleptsova ES; Limited Liability Company "EpiVac", 630559 Koltsovo, Russia.
  • Lomakin NV; Central Clinical Hospital, Administrative Directorate of the President of the Russian Federation, 121359 Moscow, Russia.
  • Vasilyeva VS; Central Clinical Hospital, Administrative Directorate of the President of the Russian Federation, 121359 Moscow, Russia.
  • Tulikov MV; Central Clinical Hospital, Administrative Directorate of the President of the Russian Federation, 121359 Moscow, Russia.
  • Gusarov VG; Pirogov National Medical and Surgical Center, 105203 Moscow, Russia.
  • Pulin AA; Pirogov National Medical and Surgical Center, 105203 Moscow, Russia.
  • Balalaeva MA; Russian Research Center of Surgery n.a. Academician B.V. Petrovsky, 119435 Moscow, Russia.
  • Erofeeva SB; Krasnogorsk City Hospital No. 1, 143403 Krasnogorsk, Russia.
  • Terpigorev SA; Moscow Regional Research and Clinical Institute n.a. M.F. Vladimirsky, 129110 Moscow, Russia.
  • Rychkova OA; Pirogov National Medical and Surgical Center, 105203 Moscow, Russia.
  • Petrov IM; Moscow Regional Research and Clinical Institute n.a. M.F. Vladimirsky, 129110 Moscow, Russia.
  • Delian VY; Institute of Motherhood and Childhood, Tyumen State Medical University, Ministry of Health of the Russian Federation, 625023 Tyumen, Russia.
  • Rafalskiy VV; Institute of Motherhood and Childhood, Tyumen State Medical University, Ministry of Health of the Russian Federation, 625023 Tyumen, Russia.
  • Tyranovets SV; Municipal Clinical Hospital No. 7, 420103 Kazan, Russia.
  • Gavrilova EV; Medical Institute, Immanuel Kant Baltic Federal University, 236041 Kaliningrad, Russia.
  • Maksyutov RA; Limited Liability Company "Clinical Research Laboratory", 111672 Moscow, Russia.
Vaccines (Basel) ; 11(5)2023 May 18.
Article en En | MEDLINE | ID: mdl-37243102

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rusia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rusia